Clinical Trial Update: FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating FG-4592 (roxadustat) for anemia in chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• FG-4592 (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Anemia | Phase 3 | Status: COMPLETED